CA0717341071
CA0717341071
Bausch Health Companies Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.26B EUR | 1.84B EUR | 2.02B EUR | 2.58B EUR |
Enterprise Value | 22.18B EUR | 20.8B EUR | 21.51B EUR | 22.12B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | 11.98x |
Forward P/E | 1.44x | -- | -- | -- |
Price to Sales | 0.21x | 0.17x | 0.19x | 0.32x |
Price to Book | -- | -- | -- | -- |
EV/Revenue | 2.04x | 1.92x | 2.04x | 2.76x |
EV/EBITDA | 5.68x | 5.24x | 5.84x | 7.73x |
Price to FCF (P/FCF) | 1.58x | 1.32x | 2.04x | 2.84x |
EV/FCF | 15.47x | 14.93x | 21.75x | 24.41x |
FCF Yield | 63.47% | 75.57% | 49.04% | 35.18% |